TUB.BR

SellFallen Favourite

Financière de Tubize SA · Healthcare · Belgium · $9.6B · Avg Vol: $4M/d

Fallen Favourite: A good business that is expensive and falling. Wait for the price to catch up.

29
StockRank
Get insider-trade alerts
Quality
54
Value
23
Momentum
40
P/E (TTM)
80.5x
peers 18.0x
ROE
5.0%
peers -2.5%
D/E
0.0x
peers 0.5x
Dividend %
0.6%
trailing yield
Director trades · 180d
None →
Buybacks · 180d
None →

ABOUT FINANCIÈRE DE TUBIZE SA

Read

Financière de Tubize SA is a Belgian mono-holding company whose primary asset is a controlling 35% stake in the global biopharmaceutical company UCB SA. The company's sole strategic objective is to support the long-term development and stability of UCB's pharmaceutical operations. For investors, Tubize offers a leveraged and often discounted vehicle to gain exposure to UCB's high-value immunology and neurology pipeline.

FINANCIAL SUMMARY (EUR)

Year2022202320242025CAGRTTM
Revenue0000——
EPS (EUR)1.911.982.022.093.1%2.20
Shares44.5M44.5M44.5M44.5M0.0%44.5M
Debt47.8M79.2M41.3M0-7.0%—
Equity1.8B1.8B1.8B1.9B2.5%—
Op CF-2.1M-2.0M-2.1M-3.4M—-3.0M
Inv CF-5.7M11.3M87.3M93.7M——
Fin CF-7.0M-9.7M-84.3M-91.4M——
Loading 1Y...
PRICE (1Y)-8.6%
201207213219226Aug 4Aug 26Sep 16
SMA 50SMA 200

Close
$203.84
RSI (14)
27.9
52W High
$286.30
From 52W High
0.7%

SCORE BREAKDOWN

Quality
54
ROIC
5.0%55.4
ROE
5.0%55.5
GP/Assets
-0.2%8.8
Op. Margin
0.0%38.6
FCF/Assets
-0.2%44.1
Piotroski
457.7
Int. Cover
50.0x89.3
D/E Ratio
0.00x98.1
Current Ratio
141.92x99.8
Value
23
P/E (TTM)
80.5x11.9
EV/EBITDA
-2584.2x25.0
P/FCF
—N/A
P/B
4.0x34.9
P/S
—N/A
Div Yield
0.6%18.4
Momentum
40
52W High %
71%53.0
RS 6M
-32%29.6
SMA 50/200
0.91x34.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
5%42.8

FUNDAMENTALS

Market Cap
$9.6B
P/E (Forward)
—
Gross Margin
—

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TUB.BR are excluded.

TickerCompanyMkt CapStockRankSignal
TUB.BRFinancière de Tubize SA(you)$9.6B29Sell
AGMBAgomAb Therapeutics NV$649M14Strong Sell
LKFTLakefront Biotherapeutics NV$1.9B68Buy
UCB.BRUCB SA$47.8B79Buy
HYL.BRHyloris Pharmaceuticals SA$143M14Strong Sell
FAGR.BRFagron NV$1.9B83Strong Buy
IBAB.BRIon Beam Applications SA$567M71Buy
NYXHNyxoah SA$163M10Strong Sell
MDXHMDxHealth SA$69M13Strong Sell
SEQUA.BRSequana Medical NV$54M13Strong Sell

Peer medians: ROE -2.5% · P/E 18.0x · Gross margin 61.5%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Financière de Tubize SA (TUB.BR): Stock Score Summary

Financière de Tubize SA (TUB.BR) has a MoatMap StockRank of 29/100 based on Quality (54/100), Value (23/100), and Momentum (40/100) factor scores. The current signal is SELL.

Financière de Tubize SA is a Belgian mono-holding company whose primary asset is a controlling 35% stake in the global biopharmaceutical company UCB SA. The company's sole strategic objective is to support the long-term development and stability of UCB's pharmaceutical operations. For investors, Tubize offers a leveraged and often discounted vehicle to gain exposure to UCB's high-value immunology and neurology pipeline.

Key Financial Metrics

Price$203.84
Market Cap$9.6B
P/E (TTM)80.50
Price/Book3.97
Return on Equity5.0%
Return on Invested Capital5.0%
Debt/Equity0.00x
Operating Margin0.0%
Dividend Yield0.6%
Free Cash Flow$-5M

Financière de Tubize SA operates in the Biotechnology industry, part of the Healthcare sector (Belgium).

Frequently Asked Questions

What is Financière de Tubize SA’s (TUB.BR) StockRank?
MoatMap’s StockRank for Financière de Tubize SA (TUB.BR) is 29/100, with a Sell signal. It is a composite of Quality (54), Value (23), and Momentum (40) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Financière de Tubize SA have an economic moat?
Financière de Tubize SA (TUB.BR) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Financière de Tubize SA a buy, hold, or sell?
MoatMap’s current signal for Financière de Tubize SA (TUB.BR) is Sell, based on a StockRank of 29/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Financière de Tubize SA in?
Financière de Tubize SA (TUB.BR) operates in the Healthcare sector, specifically the Biotechnology industry (Belgium).
Browse all ranked stocksTUB.BR deep dive reportAI ChampionsHow we score stocksSense-check another stock